FDA Staff Weighs In on Potential First mRNA Flu Shot

FDA reviewers have not raised serious efficacy or safety concerns about Moderna's mRNA flu vaccine candidate ahead of an advisory committee meeting. The vaccine could become the first mRNA-based flu shot approved by the FDA.